Use of antisense oligonucleotides or siRNA to suppress expression of eIF5A1
Details for Australian Patent Application No. 2004217437 (hide)
International Classifications
Event Publications
22 September 2005 PCT application entered the National Phase
PCT publication WO2004/078940 Priority application(s): WO2004/078940
19 November 2009 Application Accepted
Published as AU-B-2004217437
17 December 2009 Application for Amendment
The nature of the amendment is: Amend the name of the inventor to add co-inventors Cliche, Dominic; Heikkila, Elisabeth Margaret; Senchyna, Diane Michelle and Flanagan, John Gerard. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000
8 April 2010 Amendment Made
The nature of the amendment is: Amend the name of the inventor to add co-inventors Cliche, Dominic; Heikkila, Elisabeth Margaret; Senchyna, Diane Michelle and Flanagan, John Gerard
15 April 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser